IL1B and acute respiratory distress syndrome: Recent research has revealed that miR-223 blocks the differentiation of LY6G + neutrophils derived from bone marrow and the release of cytokines in peripheral blood by targeting NLRP3 expression inhibition and the release of IL-1β, thus alleviating mitochondrial damage-associated molecular patterns-induced ALI [14].